SC concerned over reports on kids, rural India exposure in third COVID wave

The top court also acknowledged the difficulties being faced by people in not getting the slots for vaccination on the app.

Topics
Coronavirus | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

A view of the Supreme Court | Photo: PTI
A view of the Supreme Court | Photo: PTI

Concerned over reports that kids and rural India may be exposed more in the third wave of COVID-19 pandemic, the Supreme Court Monday asked the Centre whether any study on these aspects has been conducted.

The top court also asked the Centre about its responsibility on the regulation of prices of vaccines and said it has seen prices of Remdesivir and some other medicines hitting the roof.

Has any study been carried out by any government for the rural areas. We have been told that children will be exposed in the third wave and that rural areas will be affected. We want to know the vaccination policy for that too, said a special bench of Justices D Y Chandrachud, L Nageswara Rao and S Ravindra Bhat.

Hearing a suo motu case on management of COVID situation in the country, the top court highlighted the digital divide between rural and urban India and questioned the Centre over mandatory registration on CoWIN App for COVID-19 vaccination, saying the policy makers must have ears on ground to effectively deal with the unprecedented pandemic crisis.

Senior advocate and amicus curiae Meenakshi Arora referred to the differential pricing policy for vaccines and said that 25 per cent of them would be going to private hospital.

She narrated incidents and said at some places, people after registering with CoWIN app instantly get calls from private hospitals.

Those who have registered on CoWIN. They have not received calls from the government agency, but they are getting calls from private hospitals that get vaccinated for Rs 900. A family of four will have to pay Rs 4,000 which is a huge amount for them, Arora said.

We have seen in this pandemic itself that prices of Remdesivir and some other medicines were hitting the roof. We have all seen. What is our responsibility here, Justice Bhat observed.

Rs 900 price is not fixed. They may choose to charge more. The Centre has not fixed this. They have only issued an advisory. If there is a shortage, it could become Rs 2,000, the bench said.

The top court also acknowledged the difficulties being faced by people in not getting the slots for vaccination on the app.

This is a real fear among the people. I have received distress calls from people across the country, that they are not getting slots, the bench said.

One of the judges at the bench suggested the Centre to tweak its vaccination policy to ensure that vulnerable people, having co-morbidities, in the same age group be given primacy in vaccination.

Senior advocate and amicus curiae Jaideep Gupta said, presently, the app does not provide this kind of facility.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Mon, May 31 2021. 20:24 IST
RECOMMENDED FOR YOU